Get started
Author

Seri Anderson

Observed names: Anderson, Seri, Link, Seri, S Anderson, Seri A. Anderson, Seri AL Anderson, Seri Link, Seri Link Anderson
ORCID: 0000-0001-7765-6399
Observed ORCID: 0000-0001-7765-6399
OpenAlex ID: A5044599824
Screening for and Treating Postpartum Depression and Psychosis: A Cost-Effectiveness Analysis
2016 · Andra Wilkinson, Seri Anderson, et al. · Maternal and Child Health Journal · 98
System Dynamics Approaches and Collective Action for Community Health: An Integrative Review
2019 · Dorothy Cilenti, Michele Issel, et al. · American Journal of Community Psychology · 51
Using Behavior Over Time Graphs to Spur Systems Thinking Among Public Health Practitioners
2018 · Larissa Calancie, Seri Anderson, et al. · Preventing Chronic Disease · 32
PDF
Tools for Supporting the MCH Workforce in Addressing Complex Challenges: A Scoping Review of System Dynamics Modeling in Maternal and Child Health
2022 · Isabella Guynn, Jessica Simon, et al. · Maternal and Child Health Journal · 13
PDF
Effects of Two Educational Posters on Contraceptive Knowledge and Intentions
2018 · Seri Anderson, Leah Frerichs, et al. · Obstetrics and Gynecology · 11
PDF
Antiseizure medications and oral contraceptives: Impact of enzyme inducers on pregnancy outcomes and costs
2021 · Seri Anderson, Josephine Mauskopf, et al. · Epilepsy & Behavior · 7
PDF
Analysis of Costs per Responder in US Adults with Paroxysmal Nocturnal Hemoglobinuria with a Suboptimal Response to Prior Eculizumab Treatment
2023 · Jesse Fishman, Seri Anderson, et al. · Hematology Reports · 6
PDF
Cost-effectiveness of a 3-antigen versus single-antigen vaccine for the prevention of hepatitis B in adults in the United States
2023 · Sandra E. Talbird, Seri A. Anderson, et al. · Vaccine · 5
Cognitive interviews to improve a patient-centered contraceptive effectiveness poster
2018 · Seri Anderson, Megan Barry, et al. · Contraception · 5
POSB145 Budget Impact of Pegcetacoplan, a Complement C3 Inhibitor, for the Treatment of Paroxysmal Nocturnal Hemoglobinuria in US Adults
2022 · S Anderson, SE Talbird, et al. · Value in Health · 4
Cost per Responder Analysis for Pegcetacoplan and Eculizumab in the Treatment of Adults with Paroxysmal Nocturnal Hemoglobinuria
2021 · Seri Anderson, Sandra Talbird, et al. · Blood · 4
EE489 Cost-Effectiveness of 3-Antigen Vs. Single-Antigen Vaccine for Prevention of Hepatitis B in Adults in the United States
2022 · S Anderson, SE Talbird, et al. · Value in Health · 1
PDF
Estimating the cost of university-based outbreaks of serogroup B meningococcal disease with different pre-matriculation vaccination policies in the United States
2023 · Katherine A. Hicks, Parinaz Ghaswalla, et al. · Journal of American College Health
PDF
EE403 Health and Economic Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in Germany: A Cost-Effectiveness Analysis
2022 · S Talbird, J Graham, et al. · Value in Health
EE541 Cost-Effectiveness and Epidemiological Impact of a Novel 3-Antigen Vaccine for the Prevention of Hepatitis B in Adults in the United Kingdom
2022 · S Talbird, J Graham, et al. · Value in Health
PDF
Abstract PS10-45: Budget impact of introducing neratinib for third-line treatment of HER2+ metastatic breast cancer in the United States
2021 · Seri AL Anderson, Justin Carrico, et al. · Cancer Research
The Cost-efffectiveness of Improved Communication of Pregnancy Risk and Contraceptive Information
2019 · Anderson, Seri · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
P4.78 Using a systems approach to design higher-impact interventions: illustrating levels of leverage for reducing concurrency-linked sexually transmitted infections in african amercian adolescents from disadvantaged communities
2017 · Pamela A Matson, Andra Wilkinson, et al.
PDF
Abstracts of the 2009 MARCUS Conference
2009 · Berg, Laura, Brown, Helena, et al. · Zenodo (CERN European Organization for Nuclear Research)
Works count: 19
Citation count: 237
H-index: 6
I10-index: 5
Year
Topic
Type